Replimune Net Income From Continuing Ops from 2010 to 2024
| REPL Stock | USD 5.27 0.17 3.33% |
Net Loss | First Reported 2017-03-31 | Previous Quarter -51.1 M | Current Value -55.1 M | Quarterly Volatility 18.3 M |
Check Replimune financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Replimune main balance sheet or income statement drivers, such as Interest Income of 935.8 K, Depreciation And Amortization of 1.4 M or Interest Expense of 1.9 M, as well as many exotic indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 1.44. Replimune financial statements analysis is a perfect complement when working with Replimune Valuation or Volatility modules.
Replimune | Net Income From Continuing Ops |
Latest Replimune's Net Income From Continuing Ops Growth Pattern
Below is the plot of the Net Income From Continuing Ops of Replimune Group over the last few years. It is Replimune's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Replimune's overall financial position and show how it may be relating to other accounts over time.
| Net Income From Continuing Ops | 10 Years Trend |
|
Net Income From Continuing Ops |
| Timeline |
Replimune Net Income From Continuing Ops Regression Statistics
| Arithmetic Mean | (63,405,153) | |
| Coefficient Of Variation | (121.92) | |
| Mean Deviation | 63,595,004 | |
| Median | (19,702,000) | |
| Standard Deviation | 77,303,546 | |
| Sample Variance | 5975.8T | |
| Range | 208.1M | |
| R-Value | (0.88) | |
| Mean Square Error | 1505.1T | |
| R-Squared | 0.77 | |
| Significance | 0.000019 | |
| Slope | (15,129,786) | |
| Total Sum of Squares | 83661.7T |
Replimune Net Income From Continuing Ops History
About Replimune Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Replimune income statement, its balance sheet, and the statement of cash flows. Replimune investors use historical funamental indicators, such as Replimune's Net Income From Continuing Ops, to determine how well the company is positioned to perform in the future. Although Replimune investors may use each financial statement separately, they are all related. The changes in Replimune's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Replimune's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Replimune Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Replimune. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Loss | -215.8 M | -205 M |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Replimune Group using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out the analysis of Replimune Correlation against competitors. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Complementary Tools for Replimune Stock analysis
When running Replimune's price analysis, check to measure Replimune's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Replimune is operating at the current time. Most of Replimune's value examination focuses on studying past and present price action to predict the probability of Replimune's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Replimune's price. Additionally, you may evaluate how the addition of Replimune to your portfolios can decrease your overall portfolio volatility.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |
Is Replimune's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Replimune. If investors know Replimune will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Replimune listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.25) | Return On Assets (0.26) | Return On Equity (0.46) |
The market value of Replimune Group is measured differently than its book value, which is the value of Replimune that is recorded on the company's balance sheet. Investors also form their own opinion of Replimune's value that differs from its market value or its book value, called intrinsic value, which is Replimune's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Replimune's market value can be influenced by many factors that don't directly affect Replimune's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Replimune's value and its price as these two are different measures arrived at by different means. Investors typically determine if Replimune is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Replimune's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.